It was reported that the blockade of IRAK1/4 is effective at eradicating myelodysplastic syndrome (MDS) cells by inhibiting growth and inducing apoptosis through the deactivation of NF-κB35. This evidence concerns the gene IRAK1 and myelodysplastic syndrome.